Abstract
Objective: To identify an appropriate risk stratification system for intermediate‐risk prostate cancer ( PCa ). Patients and Methods: We reviewed the data on 1559 patients who were treated with radical prostatectomy ( RP ) at our institution between 2005 and 2013 and classified them according to National Comprehensive Cancer Network ( NCCN ) risk groups. For our analyses, intermediate‐risk PCa was designated as unfavourable intermediate‐risk PCa if it met at least one of the following two criteria: biopsy G leason score 4 + 3 and/or presence of ≥2 intermediate‐risk criteria. All other men with intermediate‐risk PCa were designated as having favourable intermediate‐risk disease. Postoperative outcomes, including biochemical recurrence ( BCR )‐free survival, were calculated and compared using the log‐rank test and Cox proportional hazards model. Results: In multivariable analysis, biopsy G leason score 4 + 3 and multiple (≥2) intermediate‐risk criteria were observed to be independent predictors of BCR risk among men in the intermediate‐risk group undergoing RP . The favourable intermediate‐risk group had a significantly higher 5‐year BCR ‐free survival compared with the unfavourable intermediate‐risk group (87.5 vs 66.5%; P < 0.001). The unfavourable intermediate‐risk group had significantly higher 5‐year BCR ‐free survival than the high‐risk group (66.5 vs 47.9%; P < 0.001) while the favourable intermediate‐risk group had significantly lower 5‐year BCR ‐free survival than the low‐risk group (87.5 vs 93.5%; P = 0.002). Conclusions: A marked heterogeneity exists in the biochemical outcomes of contemporary patients with intermediate‐risk PCa who undergo definitive RP . According to biopsy G leason score and number of intermediate‐risk criteria present, the intermediate‐risk group should be sub‐divided into those with favourable and unfavourable intermediate‐risk disease.

This publication has 23 references indexed in Scilit: